Advanced or Metastatic Solid Tumors Recruiting Phase 2 Trials for Pemigatinib (DB15102)

IndicationStatusPhase
DBCOND0034454 (Advanced or Metastatic Solid Tumors)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs